Shanghai Shen Lian Biomedical Corporation (SHA:688098)

China flag China · Delayed Price · Currency is CNY
9.20
+0.23 (2.56%)
At close: Mar 6, 2026
Market Cap3.78B +64.0%
Revenue (ttm)288.27M -5.0%
Net Income-19.09M
EPS-0.05
Shares Out410.64M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,468,114
Average Volume3,648,880
Open8.88
Previous Close8.97
Day's Range8.88 - 9.21
52-Week Range4.97 - 17.57
Beta0.73
RSI44.95
Earnings DateApr 29, 2026

About SHA:688098

Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. It develops synthetic peptide vaccines to treat foot-and-mouth diseases. The company was founded in 2001 and is headquartered in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 374
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688098
Full Company Profile

Financial Performance

In 2025, SHA:688098's revenue was 288.27 million, a decrease of -4.99% compared to the previous year's 303.41 million. Losses were -19.09 million, -57.33% less than in 2024.

Financial Statements